1. Zhang, Wen-Song, Zhang, Rihua, Ge, Yaoqi, Kan, Jingbao, Liu, Yun. 2022. S100a16 deficiency prevents hepatic stellate cells activation and liver fibrosis via inhibiting CXCR4 expression. In Metabolism: clinical and experimental, 135, 155271. doi:10.1016/j.metabol.2022.155271. https://pubmed.ncbi.nlm.nih.gov/35914619/
2. Zhang, Haibin, Yang, Yongxiu, Xing, Wenhu, Li, Yufeng, Zhang, Shan. 2023. Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining. In BMC cancer, 23, 1124. doi:10.1186/s12885-023-11574-y. https://pubmed.ncbi.nlm.nih.gov/37978469/
3. Han, Shuying, Jin, Runbing, Huo, Lei, Su, Dongming, Liang, Xiubin. 2024. HIF-1α participates in the regulation of S100A16-HRD1-GSK3β/CK1α pathway in renal hypoxia injury. In Cell death & disease, 15, 316. doi:10.1038/s41419-024-06696-5. https://pubmed.ncbi.nlm.nih.gov/38710691/
4. Wang, Ning, Wang, Rongjiang, Tang, Jianer, Lu, Lingqun, Chen, Yu. 2022. Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway. In Contrast media & molecular imaging, 2022, 5602011. doi:10.1155/2022/5602011. https://pubmed.ncbi.nlm.nih.gov/36176934/
5. Chen, Tian, Xia, De-Meng, Qian, Chao, Liu, Shan-Rong. 2021. Integrated analysis identifies S100A16 as a potential prognostic marker for pancreatic cancer. In American journal of translational research, 13, 5720-5730. doi:. https://pubmed.ncbi.nlm.nih.gov/34150181/
6. Chen, Dongjie, Huang, Hui, Zang, Longjun, Zhu, Hongwei, Yu, Xiao. 2021. Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma. In Frontiers in immunology, 12, 728062. doi:10.3389/fimmu.2021.728062. https://pubmed.ncbi.nlm.nih.gov/34691034/
7. Zhang, Yu, Yang, Xin, Zhu, Xiao-Lin, Hao, Chun-Yan, Duan, Hu-Bin. 2021. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma. In Aging, 13, 15459-15478. doi:10.18632/aging.203103. https://pubmed.ncbi.nlm.nih.gov/34148033/
8. Zhang, Rihua, Kan, Jing Bao, Lu, Shan, Li, Dong, Liu, Yun. 2019. S100A16-induced adipogenesis is associated with up-regulation of 11 β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). In Bioscience reports, 39, . doi:10.1042/BSR20182042. https://pubmed.ncbi.nlm.nih.gov/31399502/
9. Fang, Dan, Zhang, Chengfei, Xu, Ping, Xia, Hongping, Lan, Linhua. 2021. S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways. In Cell biology and toxicology, 37, 555-571. doi:10.1007/s10565-020-09574-w. https://pubmed.ncbi.nlm.nih.gov/33389337/
10. Yang, Dashuai, Zhao, Fangrui, Zhou, Yu, Zhao, Kailiang, Ding, Youming. 2024. S100A16 is a potential target for reshaping the tumor microenvironment in the hypoxic context of liver cancer. In International immunopharmacology, 134, 112076. doi:10.1016/j.intimp.2024.112076. https://pubmed.ncbi.nlm.nih.gov/38733818/
智鼠故事 
